244 related articles for article (PubMed ID: 27856220)
61. Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland.
Mackintosh LJ; de Koning MN; Quint WG; Ter Schegget J; Morgan IM; Herd RM; Campo MS
Br J Dermatol; 2009 Jul; 161(1):56-62. PubMed ID: 19416244
[TBL] [Abstract][Full Text] [Related]
62. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
63. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
[TBL] [Abstract][Full Text] [Related]
64. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis.
Favre M; Orth G; Majewski S; Baloul S; Pura A; Jablonska S
J Invest Dermatol; 1998 Apr; 110(4):311-7. PubMed ID: 9540967
[TBL] [Abstract][Full Text] [Related]
65. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
66. The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesions.
Vella L; Sternjakob A; Lohse S; Fingerle A; Sperling T; Wickenhauser C; Stöckle M; Vogt T; Roemer K; Ołdak M; Smola S
Front Cell Infect Microbiol; 2024; 14():1336492. PubMed ID: 38510961
[TBL] [Abstract][Full Text] [Related]
67. HPV and skin carcinogenesis.
Tommasino M
Papillomavirus Res; 2019 Jun; 7():129-131. PubMed ID: 30953864
[TBL] [Abstract][Full Text] [Related]
68. Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability.
Wallace NA; Robinson K; Galloway DA
J Virol; 2014 Jun; 88(11):6112-27. PubMed ID: 24648447
[TBL] [Abstract][Full Text] [Related]
69. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
70. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.
Dust K; Carpenter M; Chen JC; Grant C; McCorrister S; Westmacott GR; Severini A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016386
[TBL] [Abstract][Full Text] [Related]
71. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients.
Morrison C; Eliezri Y; Magro C; Nuovo GJ
J Cutan Pathol; 2002 Sep; 29(8):480-9. PubMed ID: 12207742
[TBL] [Abstract][Full Text] [Related]
72. Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair.
Bruyere D; Roncarati P; Lebeau A; Lerho T; Poulain F; Hendrick E; Pilard C; Reynders C; Ancion M; Luyckx M; Renard M; Jacob Y; Twizere JC; Peiffer R; Peulen O; Delvenne P; Hubert P; McBride A; Gillet N; Masson M; Herfs M
Theranostics; 2023; 13(3):1130-1149. PubMed ID: 36793865
[No Abstract] [Full Text] [Related]
73. Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients.
Švajdler M; Mezencev R; Kašpírková J; Kacerovská D; Kazakov DV; Ondič O; Michal M
Am J Dermatopathol; 2016 Oct; 38(10):751-7. PubMed ID: 26913849
[TBL] [Abstract][Full Text] [Related]
74. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.
Pfister H; Fuchs PG; Majewski S; Jablonska S; Pniewska I; Malejczyk M
Arch Dermatol Res; 2003 Dec; 295(7):273-9. PubMed ID: 14618345
[TBL] [Abstract][Full Text] [Related]
75. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
76. Comparative study of p16 protein expression in squamous cell carcinomas from patients with epidermodysplasia verruciformis and patients without the disease.
Mattos MSG; Oliveira WR; Sotto MN
Arch Dermatol Res; 2017 Aug; 309(6):479-483. PubMed ID: 28439661
[TBL] [Abstract][Full Text] [Related]
77. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients.
de Jong-Tieben LM; Berkhout RJ; Smits HL; Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; ter Schegget J
J Invest Dermatol; 1995 Sep; 105(3):367-71. PubMed ID: 7665914
[TBL] [Abstract][Full Text] [Related]
78. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures.
Boxman IL; Mulder LH; Noya F; de Waard V; Gibbs S; Broker TR; ten Kate F; Chow LT; ter Schegget J
J Invest Dermatol; 2001 Dec; 117(6):1397-404. PubMed ID: 11886500
[TBL] [Abstract][Full Text] [Related]
79. Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints.
Dong W; Arpin C; Accardi R; Gissmann L; Sylla BS; Marvel J; Tommasino M
Oncogene; 2008 May; 27(20):2923-8. PubMed ID: 18026133
[TBL] [Abstract][Full Text] [Related]
80. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
